|
|
|
|
An open source pharma roadmap
|
|
|
|
|
|
|
|
نویسنده
|
balasegaram m. ,kolb p. ,mckew j. ,menon j. ,olliaro p. ,sablinski t. ,thomas z. ,todd m.h. ,torreele e. ,wilbanks j.
|
|
منبع
|
plos medicine - 2017 - دوره : 14 - شماره : 4
|
|
چکیده
|
[no abstract available]
|
|
|
|
|
آدرس
|
médecins sans frontières,geneva, Switzerland, department of pharmaceutical chemistry,philipps-university marburg,marburg, Germany, national institutes of health,national center for advancing translational sciences (ncats),bethesda,md,united states,lumo pharma,austin,tx, United States, mcgill university institute for the study of international development,montreal, Canada, unicef/undp/world bank/who special programme for research and training in tropical diseases (tdr),world health organization,geneva,switzerland,centre for tropical medicine and global health,nuffield department of clinical medicine,university of oxford,oxford, United Kingdom, transparency life sciences,new york,ny, United States, open source drug discovery,council of scientific and industrial research (csir),new delhi,india,directorate of risk assessment,government of india,new delhi, India, school of chemistry,the university of sydney,sydney, Australia, public health program,open society foundations,new york,ny, United States, sage bionetworks,seattle,wa, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|